81 related articles for article (PubMed ID: 11773010)
1. TGFbeta1-dependent contraction of fibroblasts is mediated by the PDGFalpha receptor.
Ikuno Y; Kazlauskas A
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):41-6. PubMed ID: 11773010
[TBL] [Abstract][Full Text] [Related]
2. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
[TBL] [Abstract][Full Text] [Related]
3. Growth factors outside the PDGF family drive experimental PVR.
Lei H; Velez G; Hovland P; Hirose T; Gilbertson D; Kazlauskas A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3394-403. PubMed ID: 19324843
[TBL] [Abstract][Full Text] [Related]
4. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor.
Ikuno Y; Kazlauskas A
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2406-11. PubMed ID: 12091444
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.
Ikuno Y; Leong FL; Kazlauskas A
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3107-16. PubMed ID: 10967071
[TBL] [Abstract][Full Text] [Related]
6. PI3K and PLCgamma play a central role in experimental PVR.
Ikuno Y; Leong FL; Kazlauskas A
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):483-9. PubMed ID: 11818394
[TBL] [Abstract][Full Text] [Related]
7. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.
Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073
[TBL] [Abstract][Full Text] [Related]
8. Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy.
Pena RA; Jerdan JA; Glaser BM
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2804-8. PubMed ID: 8188474
[TBL] [Abstract][Full Text] [Related]
9. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction.
Carrington L; McLeod D; Boulton M
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1210-6. PubMed ID: 10752962
[TBL] [Abstract][Full Text] [Related]
10. Platelet-Derived Growth Factor Receptor Activation Promotes the Prodestructive Invadosome-Forming Phenotype of Synoviocytes from Patients with Rheumatoid Arthritis.
Charbonneau M; Lavoie RR; Lauzier A; Harper K; McDonald PP; Dubois CM
J Immunol; 2016 Apr; 196(8):3264-75. PubMed ID: 26976956
[TBL] [Abstract][Full Text] [Related]
11. The requirement of tyrosines 579 and 581 for maximal ligand-dependent activation of the betaPDGFR is influenced by noncytoplasmic regions of the receptor.
Nickas ME; Bernard A; Kazlauskas A
Exp Cell Res; 2001 Apr; 265(1):80-9. PubMed ID: 11281646
[TBL] [Abstract][Full Text] [Related]
12. TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling.
Jester JV; Huang J; Petroll WM; Cavanagh HD
Exp Eye Res; 2002 Dec; 75(6):645-57. PubMed ID: 12470966
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.
Lei H; Rheaume MA; Kazlauskas A
Exp Eye Res; 2010 Mar; 90(3):376-81. PubMed ID: 19931527
[TBL] [Abstract][Full Text] [Related]
16. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
Liu T; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
[TBL] [Abstract][Full Text] [Related]
17. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.
Zhou X; Tan FK; Stivers DN; Arnett FC
Arthritis Rheum; 2000 May; 43(5):1068-73. PubMed ID: 10817561
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation.
Bossé Y; Thompson C; Stankova J; Rola-Pleszczynski M
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):746-53. PubMed ID: 16439802
[TBL] [Abstract][Full Text] [Related]
19. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism.
Lindroos PM; Coin PG; Badgett A; Morgan DL; Bonner JC
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):283-92. PubMed ID: 9070613
[TBL] [Abstract][Full Text] [Related]
20. PDGF-D, a new protease-activated growth factor.
LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
